RESEARCHER PROFILE

Daniel Rodrigues de Bastos

← Back to Universidad Privada del Este

D

Universidad Privada del Este

Breast Cancer Treatment StudiesBreast Lesions and CarcinomasCancer-related molecular mechanisms researchCervical Cancer and HPV ResearchMicroRNA in disease regulation

Daniel Rodrigues de Bastos works in Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer-related molecular mechanisms research, Cervical Cancer and HPV Research, MicroRNA in disease regulation. Recorded institutional associations include Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.

27Publications
88Citations
6H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors

    2020 · 23 citations
  2. The expression patterns and prognostic significance of pleckstrin homology-like domain family A (PHLDA) in lung cancer and malignant mesothelioma

    2021 · 17 citations
  3. Prognostic and Predictive Value of Pleckstrin Homology-Like Domain, Family A Family Members in Breast Cancer

    2020 · 12 citations
  4. CD40/CD40L expression and its prognostic value in cervical cancer

    2023 · 9 citations
  5. An In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients

    2020 · 7 citations
  6. High Levels of Superoxide Dismutase 2 Are Associated With Worse Prognosis in Patients With Breast Cancer

    2024 · 6 citations
  7. RISK FACTORS RELATED TO BREAST CANCER DEVELOPMENT

    2019 · 4 citations
  8. Prognostic value of Maspin protein level in patients with triple negative breast cancer

    2024 · 3 citations
  9. Computational insights into CRISP3 downregulation in cervical cancer and its cervical lineages pattern

    2024 · 3 citations
  10. Padrão de metástase no câncer de mama triplo negativo

    2017 · 2 citations
  11. ROPN1 Gene Expression as a Prognostic and Predictive Biomarker in Aggressive Breast Cancer: Clinical Implications and Survival Association

    2025 · 1 citations
  12. Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

    2026 · 1 citations
  13. Análise da expressão de miR-10b e miR-7 potencialmente associados à expressão de BRCA1 em carcinomas de mama

    2017 · 0 citations
  14. BRCA1 AND microRNAs 7, 10B, 205ab, 218ª expression as prognostic markers in primary breast cancers – a retrospective cohort study

    2018 · 0 citations
  15. The long non-coding RNA ADAMTS9-AS2 was identified as a potential prognostic biomarker in triple-negative breast cancer

    2020 · 0 citations
  16. Oncology and Hematology in the ICU

    2022 · 0 citations
  17. Annexin A1 Regulates Retinal Gliosis in Diabetic Retinopathy

    2023 · 0 citations
  18. Altered Expression of CYSLTR1 is Associated With Adverse Clinical Outcome in Triple Negative Breast Tumors: An In Silico Approach

    2023 · 0 citations
  19. Estudo do receptor Frizzled classe 9 (FZD9), um potencial biomarcador prognóstico e alvo terapêutico

    2023 · 0 citations
  20. Study of Frizzled receptor class 9 (FZD9), a potential prognostic biomarker and therapeutic target

    2023 · 0 citations
  21. Author response for "Targeted modulation of IGFL2-AS1 reveals its translational potential in cervical adenocarcinoma"

    2025 · 0 citations
  22. Association of NK6 homeobox 1 promoter methylation with HPV infection, histological sub-type, and patient outcomes in cervical lesions

    2026 · 0 citations
  23. Frizzled‐9 Expression Is Associated With Aggressive Clinicopathological Features and Reduced Overall Survival in Invasive Breast Carcinoma

    2026 · 0 citations
  24. Evaluation of cytokine release syndrome in non-Hodgkin lymphoma therapy with bispecific antibodies: A meta-analysis of clinical trials

    2026 · 0 citations
  25. Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy

    2026 · 0 citations

← Return to the university profile